|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Cancer
:
Bladder
Surgery should occur within 3 months of diagnosis of bladder carcinoma
Bladder cancer patients whose surgery was delayed for more than three months after their diagnosis were more likely to die from their disease than patients whose surgery was performed sooner, according to a study by researchers at the University of Michigan Comprehensive Cancer Center.
Mar 28, 2006, 21:02
Latest Research
:
Cancer
:
Bladder
Urinary Protein NMP22 Can Help Detect Bladder Cancer Recurrence
Measurement of a certain protein in urine can increase the ability to detect bladder cancer recurrence, with test results available during the patient�s visit, according to a study in the January 18 issue of JAMA.
Jan 21, 2006, 21:38
Latest Research
:
Cancer
:
Bladder
Telomerase activity in urine useful for detecting bladder cancer in men
Measurement of an enzyme level (telomerase activity) in urine appears useful for detection of bladder cancer in men, according to a study in the October 26 issue of JAMA. The incidence of human bladder cancer has greatly increased over the last few decades, with more than 60,000 new cases diagnosed each year in the United States alone, and now represents the 4th most common malignancy in men and the 10th most common in women, according to background information in the article. At present, about 20 percent of patients die each year, but when the disease is diagnosed and treated in the early stage, the chances of survival are good, indicating the importance of a timely and accurate diagnosis.
Oct 26, 2005, 23:21
Latest Research
:
Cancer
:
Bladder
FDA Clearance to Initiate Chemophase Clinical Trial for Superficial Bladder Cancer
Halozyme Therapeutics, Inc.(Amex: HTI), a biopharmaceutical company focused on the development and commercialization of recombinant human enzymes, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its Chemophase(TM) Investigational New Drug (IND)application. The initial clinical protocol under this IND is a Phase I study designed to evaluate a single intravesical administration of Chemophase along with mitomycin in patients with superficial bladder cancer.
Aug 11, 2005, 23:28
Latest Research
:
Cancer
:
Bladder
Broccoli compounds may help in bladder cancer
Researchers have isolated compounds from the vegetable broccoli that they believe may help prevent or slow the progress of bladder cancer.
Jul 29, 2005, 18:17
Latest Research
:
Cancer
:
Bladder
More dependable, less expensive tool to detect bladder cancer earlier
In a new study researchers tested the NMP22 tumor marker assay in 1,331 patients at high risk for bladder cancer. Researchers determined through cystoscopy that 79 of the 1,331 patients examined had bladder cancer. The NMP22 assay was positive in 55 percent of the cases (44 out of 79 cases) while the conventional cytology test detected about 16 percent of malignancies (12 out of 76 cases).
Feb 16, 2005, 19:42
|
